Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Bruce Carleton, Véronique Michaud et al.|Therapeutic Drug Monitoring|2015Cited by 77
Brain structure, working memory and response inhibition in childhood leukemia survivorsEllen van der Plas, Brian J. Nieman, Russell Schachar et al.|Brain and Behavior|2016Cited by 59
Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate.Ellen van der Plas, Russell Schachar, Brian J. Nieman et al.|PubMed|2015Cited by 43
Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measuresEllen van der Plas, Brenda J. Spiegler, Lauren Erdman et al.|Child Neuropsychology|2017Cited by 41
Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemiaEllen van der Plas, Brian J. Nieman, Russell Schachar et al.|Pediatric Research|2020Cited by 26